Startups
Crystalys Therapeutics is developing innovative therapies to transform the treatment of gout
Overview
Total raised
$130M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 22, 2026 | Venture capital & startup funding roundup, July 22, 2026: Andreessen Horowitz, Redpoint Ventures, Sequoia Capital, Insight Partners & more | If there was one clear signal in today’s funding landscape, it was that venture investors are no longer paying simply for “AI exposure.” They are paying for control points: endpoint security, military cyber operations, healthcare billing in... |
| Jul 22, 2026 | Crystalys Therapeutics Raises $130 Million To Bring Late-Stage Gout Drug To U.S. Market | Crystalys Therapeutics raises $130 million in an oversubscribed Series B financing round. The funding will help Crystalys take its late-stage gout drug to market. Series B comes less than a year after its impressive $205 million Series A of... |
| Jul 22, 2026 | Crystalys Therapeutics Raises $130M in Series B Funding | Crystalys Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical company, raised $130M in Series B funding. The round was led by Frazier Life Sciences with participation from Wellington Management, HBM Healthcare Investments, ... |
| Sep 30, 2025 | Crystalys Therapeutics Raises in $205M Series A Funding | Crystalys Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical company, raised $205M in Series A funding. The round was led by Novo Holdings, SR One and Catalys Pacific with participation from a broad syndicate of investors,... |
| Crystalys Therapeutics | “Crystalys Therapeutics - Passionate. Dedicated. We improve lives.” |
Reviews 0
FAQ about Crystalys Therapeutics
How much funding has Crystalys Therapeutics raised?
Crystalys Therapeutics has raised $130M in total across 1 funding round.
What has the press written about Crystalys Therapeutics?
Parsers VC has collected 6 articles mentioning Crystalys Therapeutics, among them “Venture capital & startup funding roundup, July 22, 2026: Andreessen Horowitz, Redpoint Ventures, Sequoia Capital, Insight Partners & more” (Jul 22, 2026) and “Crystalys Therapeutics Raises $130 Million To Bring Late-Stage Gout Drug To U.S. Market” (Jul 22, 2026).
Is Crystalys Therapeutics still active?
Yes, Crystalys Therapeutics is active; its latest activity on Parsers VC dates from Jul 27, 2026.